{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:20Z","timestamp":1793442680365,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1477300"],"award-info":[{"award-number":["24ZR1477300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDA0580000"],"award-info":[{"award-number":["XDA0580000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472091"],"award-info":[{"award-number":["82472091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82530069"],"award-info":[{"award-number":["82530069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011198","name":"Shanghai Institute of Materia Medica Chinese Academy of Sciences State Key Laboratory of Drug Research","doi-asserted-by":"publisher","award":["SIMM0120231004"],"award-info":[{"award-number":["SIMM0120231004"]}],"id":[{"id":"10.13039\/501100011198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["TM202301H003"],"award-info":[{"award-number":["TM202301H003"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115425","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:09:02Z","timestamp":1790780942000},"page":"115425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Systematic PEGylation optimization of Dar3A-based FAP-targeted PET probes and first-in-human study"],"prefix":"10.1016","volume":"399","author":[{"given":"Renda","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115425_bb0005","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/acs.chemrev.8b00281","article-title":"Radioactive transition metals for imaging and therapy","volume":"119","author":"Boros","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0010","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/acs.chemrev.8b00294","article-title":"Radioactive main group and rare earth metals for imaging and therapy","volume":"119","author":"Kostelnik","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0015","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1039\/D2CS00407K","article-title":"Medicinal inorganic chemistry - challenges, opportunities and guidelines to develop the next generation of radioactive, photoactivated and active site inhibiting metal-based medicines","volume":"51","author":"Lengacher","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0020","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1021\/acs.chemrev.5c00641","article-title":"Chemical tools to characterize the coordination chemistry of radionuclides for radiopharmaceutical applications","volume":"125","author":"Boros","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0025","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.115425_bb0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1039\/C3CS60304K","article-title":"Matching chelators to radiometals for radiopharmaceuticals","volume":"43","author":"Price","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cbpa.2021.03.001","article-title":"Emerging chelators for nuclear imaging","volume":"63","author":"Sneddon","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.115425_bb0040","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00259-022-05750-8","article-title":"Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers","volume":"49","author":"Xu","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.115425_bb0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2967\/jnumed.125.271421","article-title":"Development of Dar3A chelator and construction of FAP-targeted PET probe as proof of concept and for first-in-human evaluation","volume":"67","author":"Li","year":"2026","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2026.115425_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2009.01.003","article-title":"Cancer-associated fibroblasts and tumor growth\u2014bystanders turning into key players","volume":"19","author":"Ostman","year":"2009","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jconrel.2026.115425_bb0055","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2026.115425_bb0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"FAPI PET\/CT: will it end the hegemony of (18)F-FDG in oncology?","volume":"62","author":"Hicks","year":"2021","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2026.115425_bb0065","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/jm500031w","article-title":"Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)","volume":"57","author":"Jansen","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2026.115425_bb0075","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jconrel.2026.115425_bb0080","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1021\/acs.molpharmaceut.3c00248","article-title":"Fibroblast activation protein targeting probe with Gly-pro sequence for PET of glioblastoma","volume":"20","author":"Lai","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115425_bb0085","doi-asserted-by":"crossref","first-page":"21739","DOI":"10.1021\/acs.jmedchem.5c02102","article-title":"Structure-property investigation of new \u201cKetoFAPI\u201d inhibitors of fibroblast activation protein (FAP): discovery of highly potent, selective compounds with prolonged residence times and promising radiotheranostic potential","volume":"68","author":"Brzeminski","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115425_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114908","article-title":"Chelator-guided radiosynthesis, preclinical evaluation, and clinical study of [(68)Ga]Ga-TRAP-(FAPI)(3) for positron emission tomography imaging of tumors","volume":"394","author":"Wang","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115425_bb0100","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1007\/s00259-022-05842-5","article-title":"Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy","volume":"49","author":"Zboralski","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.115425_bb0105","doi-asserted-by":"crossref","first-page":"24759","DOI":"10.1021\/acs.jmedchem.5c01861","article-title":"Small molecule-drug conjugates: an emerging drug design strategy for targeted therapeutics","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0110","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1021\/acs.jmedchem.4c03133","article-title":"Modification of asp-peptide adapters: giving the FAP-targeted radioligand a \u201csquirrel tail\u201d","volume":"68","author":"Meng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0115","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1007\/s00259-023-06282-5","article-title":"Noninvasive imaging of FAP expression using positron emission tomography: a comparative evaluation of a [(18)F]-labeled glycopeptide-containing FAPI with [(18)F]FAPI-42","volume":"50","author":"Huang","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jconrel.2026.115425_bb0120","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1021\/acs.jmedchem.5c03486","article-title":"Structure-guided designed [(18)F]-labeled FAPI for enhanced hydrophilicity: from preclinical to first-in-human study","volume":"69","author":"Mu","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0125","doi-asserted-by":"crossref","first-page":"9973","DOI":"10.1021\/acs.jmedchem.4c02961","article-title":"Design, synthesis, and evaluation of a novel positron emission tomography tracer targeting fibroblast activation protein: from bench to bedside","volume":"68","author":"Tang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115425_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: the great versatility achieved after forty years of research","volume":"161","author":"Pasut","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115425_bb0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nucmedbio.2014.03.014","article-title":"PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists","volume":"41","author":"Jamous","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2026.115425_bb0145","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1021\/acs.molpharmaceut.5c01874","article-title":"Synthesis and in vivo and in vitro properties of (99m)Tc-labeled fibroblast activation protein inhibitors","volume":"23","author":"Tang","year":"2026","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115425_bb0150","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.jconrel.2026.115425_bb0155","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nrd2082","article-title":"Drug-target residence time and its implications for lead optimization","volume":"5","author":"Copeland","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115425_bb0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.115425_bb0165","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1021\/acscentsci.9b00770","article-title":"Drug-target residence time affects in vivo target occupancy through multiple pathways","volume":"5","author":"Lee","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2026.115425_bb0170","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1535-7163.MCT-09-0195","article-title":"A modeling analysis of the effects of molecular size and binding affinity on tumor targeting","volume":"8","author":"Schmidt","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.115425_bb0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"Chauhan","year":"2011","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.jconrel.2026.115425_bb0180","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1021\/acs.jmedchem.4c00448","article-title":"FAP radioligand linker optimization improves tumor dose and tumor-to-healthy organ ratios in 4T1 syngeneic model","volume":"67","author":"Lindeman","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.115425_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202410410","article-title":"Precise PEGylation modulates the in vivo fate of peptide radiopharmaceuticals","volume":"21","author":"Shen","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115425_bb0190","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1021\/cbmi.6c00005","article-title":"FAPI dimerization for theranostic applications: molecular design, preclinical validation, and clinical translation","volume":"4","author":"Jiang","year":"2026","journal-title":"Chem. Biomed. Imag."},{"key":"10.1016\/j.jconrel.2026.115425_bb0195","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.drudis.2008.07.005","article-title":"Do enthalpy and entropy distinguish first in class from best in class?","volume":"13","author":"Freire","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115425_bb0200","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"J. Exp. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:44:19Z","timestamp":1793439859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0168365926008291"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115425","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic PEGylation optimization of Dar3A-based FAP-targeted PET probes and first-in-human study","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115425"}}